This also might be a reason why GC has alluded to a spin off. A spin off will give leverage too because the separate company will be financed by institutions, which will completely bypass any big pharmas attempt to leverage the company. I think GC and gang are at the poker table showing their aces, which scares the guys holding the kings. They have the leverage because they own the patents. I think they are really feeling the waters for the best partnership for them, and that probably pisses off the powers that be.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links